†with Suda as the first affiliation; #co-first authors; *corresponding author
1. †Cao B, Li J, Zhu J, Shen M, Han K, Zhang Z, Yu Y, Wang Y, Wu D, Chen S, Sun A, Tang X, Zhao Y, Qiao C, Hou T, Mao X*. The anti-parasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity. J Biol Chem 2013;288:34181-9.
2. †Cao B, Li J, Mao X*. Dissecting bortezomib: development, application, adverse effects and future direction. Curr Pharm Des 2013;19:3190-200.
3. †Cao Z#, Bao M#, Miele L, Sarkar FH, Wang Z*, Zhou Q*. Tumor vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis. Eur J Cancer 2013;49:3914-23. *co-corresponding authors
4. †Cao Z#, Shang B#, Zhang G#, Miele L, Sarkar FH, Wang Z*, Zhou Q*. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochim Biophys Acta 2013;1836:273-86. *co-corresponding authors
5. †Cao Z#, Yang P#, Zhou Q*. Multiple biological functions and pharmacological effects of lycorine. Sci China Chem 2013;56:1382-91.
6. †Cao Z#, Yu D#, Fu S#, Zhang G, Pan Y, Bao M, Tu J, Shang B, Guo P, Yang P, Zhou Q*. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett 2013;218:174-85.
7. Chen X, Zhang Y, Wang Y, Li D, Zhang L, Wang K, Luo X, Yang Z, Wu Y, Liu J*. PDK1 regulates platelet activation and arterial thrombosis. Blood 2013;121:3718-26.
8. †Dong N, Fang C, Jiang Y, Zhou T, Liu M, Zhou J, Shen J, Fukuda K, Qin J, Wu Q*. Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment. J Biol Chem 2013;288:7867-74.
9. Dong N, Wu Q: Corin. In: Handbook of Proteolytic Enzymes. 3rd Edition, (Rawlings ND, Salvesen GS, Eds), pp 3007-10, Academic Press, London, 2013.
10. †Fang C#, Shen L#, Dong L, Liu M, Shi S, Dong N*, Wu Q*. Reduced urinary corin levels in patients with chronic kidney disease. Clin Sci 2013;124:709-17. *co-corresponding authors
11. †Gao L#, Liu M#, Dong N, Jiang Y, Lin CY, Huang M, Wu D*, Wu Q*. Matriptase is highly up-regulated in chronic lymphocytic leukemia and promotes cancer cell invasion. Leukemia 2013;27:1191-4. *co-corresponding authors
12. Guo D, Zhu L, Huang Z, Zhou H, Ge Y, Ma W, Wu J, Zhang X, Zhou X, Zhang Y, Zhao Y*, Gu N*. Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 2013;34:7884-94. *co-corresponding authors
13. †Guo P, Gao A, Zhang G, Han H, Zhou Q*. Decoding the knots of initiation of oncogenic epithelial-mesenchymal transition in tumor progression. Curr Cancer Drug Targets 2013;13:996-1011.
14. †He Y*, Zhao Y, Zhu M, Wu Q, Ruan C*. Detection of autoantibodies against platelet glycoproteins in patients with immune thrombocytopenic purpura by flow cytometric immunobead array. Clin Chim Acta 2013;415:176-80. *co-corresponding authors
15. †Li J#, Cao B#, Zhou S, Zhu J, Zhang Z, Hou J, Mao X*. Cyproheptadine-induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signaling. Eur J Haematol 2013;91:514-21.
16. †Li W, Tang X, Yi W, Ren L, Chu C, Wu Y, Ozaki Y, Zhang J, Zhu L*. Glaucocalyxin A inhibits platelet activation and thrombus formation via collagen receptor GPVI pathway. PLoS One 2013;8:e85120.
17. †Li X, Yao H, Chen Z, Wang Q, Zhao Y*, Chen S*. Somatic mutations of PHF6 in patients with chronic myeloid leukemia in blast crisis. Leuk Lymphoma 2013;54:671-2. *co-corresponding authors
18. Li Y#, Ma J#, Qian X, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z*. Regulation of EMT by notch signaling pathway in tumor progression. Curr Cancer Drug Targets 2013;13:957-62.
19. †Liu R#, Cao Z#, Pan Y, Zhang G, Yang P, Guo P, Zhou Q*. Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. Anticancer Drugs 2013;24:667-76.
20. †Liu X#, Zhang J#, Wu J, Zhou L, Ren Y, Yang W, Ming Z, Chen B, Wang J, Zhang Y*, Yang J*. Inhibition of elongation factor-2 kinase augments the antitumor activity of temozolomide against glioma. PloS One 2013;8:e81345. *co-corresponding authors
21. †Liu Y, Cai Y, Dai L, Chen G, Ma X, Wang Y, Xu T, Jin S, Wu X, Qiu H, Tang X, Li C, Sun A, Wu D, Liu H*. The expression of Th17-associated cytokines in human acute graft-versus-host disease. Biol Blood Marrow Transplant 2013;19:1421-9.
22. †Lu Q#, Dong N#, Wang Q, Yi W, Wang Y, Zhang S, Gu H, Zhao X, Tang X, Jin B, Wu Q, Brass LF, Zhu L*. Increased levels of plasma soluble Sema4D in patients with heart failure. PLoS One 2013;8:e64265.
23. †Lu Y#, Lu J#, Liu Q#, Niu J, Zhang S, Wu Q, Qi X*. A c. 464T>A mutation in VHL gene in a Chinese family with VHL syndrome. J Neurooncol 2013;111:313-8.
24. Ma J#, Cheng L#, Liu H, Zhang J, Shi Y, Zeng F, Miele L, Sarkar FH, Xia J, Wang Z. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr Drug Targets 2013;14:1150-6.
25. †Mao X*. Targeting the ubiquitin-proteasome pathway-current perspectives and future directions. Curr Pharm Des 2013;19: 3173-4.
26. †Mou P#, Zeng Z#, Li Q#, Liu X, Xin X, Wannemacher KM, Ruan C, Li R, Brass LF, Zhu L*. Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets. Blood 2013;121:4221-30.
27. Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. PML-RARα cooperates with SOX4 in acute myeloid leukemia. Haematologica 2013;98:424-7.
28. †Song YH#*, Song JL, Delafontaine P#, Godard MP*. The therapeutic potential of IGF-I in skeletal muscle repair. Trends Endocrinol Metab 2013;24:310-9. *co-corresponding authors
29. †Wang L#, Wu Y#*, Zhou J, Ahmad SS, Mutus B, Garbi N, Hämmerling G, Liu J, Essex DW*. Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin. Blood 2013;122:3642-50. *co-corresponding authors
30. Wang R#, Ma J#, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Functional role of miR-34 family in human cancer. Curr Drug Targets 2013;14:1185-91.
31. Wu Q#, Wang R#, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, Chen Y*, Wang Z*. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway. Oncotarget 2013;4:1999-2009. *co-corresponding authors
32. Xiong Y, Hu Z, Han X, Jiang B, Zhang R, Zhang X, Lu Y, Geng C, Li W, He Y, Huo Y, Shibuya M, Luo J*. Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways. Cell Res 2013;23:820-34.
33. †Xu Z#, Li Y#, Mao ZJ, Yin B*. The development of APE-PCR for the cloning of genomic insertion sites of DNA elements. Biologia 2013;68:766-72.
34. Yin S, Shi M, Kong T, Zhang C, Han K, Cao B, Zhang Z, Du X, Tang Q, Mao X*, Liu Z*. Preparation of S14161 and its analogues and the discovery of 6-bromo-8-ethoxy-3-nitro-2H-chromene as a more potent antitumor agent in vitro. Bioorg Med Chem Lett 2013;23:3314-9. *co-corresponding authors
35. Yin S, Zhang C, Mao X, Liu Z*. An efficient synthesis of (R)- and (S)-8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene. Tetrahedron: Asymmetry 2013;24:230-323.
36. †Zhang G#, Yang P#, Guo P#, Miele L, Sarkar FH, Wang Z*, Zhou Q*. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer. Biochim Biophys Acta 2013;1836:49-59.
37. †Zhang J#, Tang J#, Cao B, Zhang Z, Li J, Schimmer AD, He S, Mao X*. The natural pesticide dihydrorotenone induces human plasma cell apoptosis by triggering endoplasmic reticulum stress and activating p38 signaling pathway. PLoS One 2013;8:e69911.
38. Zhang S, Wen G, Huang SX, Wang J, Tong J, Hei TK*. Mitochondrial alteration in malignantly transformed human small airway epithelial cells induced by alpha particles. Int J Cancer 2013;132:19-28.
39. †Zhang S, Niu Y, Yuan N, Zhang A, Chao D, Xu Q, Wang L, Zhang X, Zhao W, Zhao Y, Wang J*. Role of autophagy in acute myeloid leukemia therapy. Chin J Cancer 2013;32:130-5. *corresponding author
40. Zhang SH, Zhang Y, Shen J, Zhang S, Chen L, Gu J, Mruk JS, Cheng G, Zhu L, Kunapuli SP, Ding Z. Tumor vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid inhibits platelet activation and thrombosis via inhibition of thromboxane A2 signaling and phosphodiesterase. J Thromb Haemost 2013;11:1855-66.
41. †Zhang Z, Song L, Dong J, Guo D, Du X, Cao B, Zhang Y, Gu N, Mao X*. A promising combo gene delivery system developed from (3-aminopropyl) triethoxysilane-modified iron oxide nanoparticles and cationic polymers. J Nanopart Res 2013;15:1659-70.
42. †Zhang Z#, Du X#, Cao B, Zhao C, Zhao Y, Mao X*. The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma. Anticancer Drugs 2013;24:792-8.
43. †Zhou H#, Liu W#, Zhu J, Liu M, Fang C, Wu Q*, Dong N*. Reduced serum corin levels in patients with osteoporosis. Clin Chim Acta 2013;426:152-6. *co-corresponding authors
44. †Zhou Y, Wu Q*. Role of corin and atrial natriuretic peptide in preeclampsia. Placenta 2013;34:89-94.
45. †Zhuang W, Cen J, Zhao Y, Chen Z*. Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line. Oncol Rep 2013;30:185-92.